Medical Dialogues5h
Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1
Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
XRP News Today: SEC, SWIFT, and ETFs—Trio of Triggers for XRP Price Action
XRP’s price outlook hinges on SEC’s appeal withdrawal, ETF approval prospects, and Ripple’s US expansion amid growing ...
Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data ...
Japanese Yen Weekly Forecast: Private Consumption, Labor Markets, and Trump in Focus
USD/JPY eyes key Japan data and US jobs report as BoJ rate hike bets build. Tariff risks and inflation influence Yen and ...
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...